Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 10, 2024

SELL
$32.18 - $46.57 $50,490 - $73,068
-1,569 Reduced 12.98%
10,519 $473,000
Q3 2023

Oct 26, 2023

SELL
$44.2 - $50.2 $23,647 - $26,857
-535 Reduced 4.24%
12,088 $550,000
Q2 2023

Jul 14, 2023

SELL
$31.86 - $67.26 $130,116 - $274,689
-4,084 Reduced 24.44%
12,623 $547,000
Q1 2023

Apr 18, 2023

BUY
$45.44 - $74.26 $194,710 - $318,204
4,285 Added 34.5%
16,707 $1.1 Million
Q4 2022

Jan 24, 2023

BUY
$41.39 - $81.0 $69,245 - $135,513
1,673 Added 15.56%
12,422 $0
Q3 2022

Nov 01, 2022

SELL
$72.36 - $113.1 $226,559 - $354,116
-3,131 Reduced 22.56%
10,749 $777,000
Q2 2022

Jul 27, 2022

BUY
$87.2 - $114.05 $330,052 - $431,679
3,785 Added 37.49%
13,880 $1.49 Million
Q1 2022

Apr 29, 2022

BUY
$94.19 - $124.49 $34,850 - $46,061
370 Added 3.8%
10,095 $1.12 Million
Q4 2021

Apr 08, 2022

BUY
$119.57 - $139.07 $49,860 - $57,992
417 Added 4.48%
9,725 $1.25 Million
Q3 2021

Oct 21, 2021

BUY
$109.17 - $142.35 $329,256 - $429,327
3,016 Added 47.93%
9,308 $1.24 Million
Q2 2021

Aug 05, 2021

BUY
$100.34 - $115.69 $59,802 - $68,951
596 Added 10.46%
6,292 $680,000
Q1 2021

Apr 28, 2021

BUY
$101.51 - $125.27 $131,556 - $162,349
1,296 Added 29.45%
5,696 $600,000
Q4 2020

Jan 20, 2021

BUY
$85.88 - $105.36 $6,698 - $8,218
78 Added 1.8%
4,400 $458,000
Q3 2020

Nov 03, 2020

BUY
$72.74 - $92.5 $12,220 - $15,540
168 Added 4.04%
4,322 $370,000
Q2 2020

Jul 30, 2020

BUY
$48.02 - $79.04 $199,475 - $328,332
4,154 New
4,154 $304,000
Q1 2020

Apr 28, 2020

SELL
$36.95 - $62.95 $137,195 - $233,733
-3,713 Closed
0 $0
Q4 2019

Feb 04, 2020

BUY
$47.06 - $56.64 $174,733 - $210,304
3,713 New
3,713 $209,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Park Avenue Securities LLC Portfolio

Follow Park Avenue Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.